New York investment mission makes final preparations

Supported by the Australian Government and Ernst & Young, AusBiotech is about to host the ‘Australian Life Science Investment Showcase: New York 2012’ prior to the BIO 2012 convention (Boston). The June mission will feature 13 companies and three places are remaining for companies that wish to present at the investment showcase.

The annual New York Showcase has become a ‘must attend’ for investors interested in life sciences and looking for an overview of Australasia’s top companies, with emerging therapeutics and medical technologies.

Investor and partnering interest to attend has already been received from: Achelous Partners, Edison Investment Research, Burrill & Company, Daiiko Sankyo, The Lind Partners, Aisling Capital, Cowen Healthcare, Madison Williams, HLM Ventures, SR One, Atlas Ventures, Flagship Ventures, Advanced Technology Ventures, Boston Millenia Partners, Bergen Asset Management, Polaris Ventures, Van Leeuwenhoeck Institute Inc, Elservier, AGS Capital and C4 Capital.

Victorian companies may be eligible for presentation fee subsidies and funding through the TRIP program.

Presenting companies to date are: Agenix (AGX), Anteo Diagnostics (ADO), BioDiem (BDO), Broadvector Limited, Circadian Technologies (CIR), Genetic Technologies (GTG), Living Cell Technologies (LCT), Phosphagenics (POS), Phylogica (PYT), PolyBatics, Prana Biotechnology (PBT), QUE Oncology and Viralytics (VLA).

The New York showcase will be held Friday 15 June 2012 at Ernst & Young Corporate Headquarters, 5 Times Square, New York, and following this the Australian delegation will continue to BIO Boston, along with Australian VIPs:

• The Honourable Alex Chernov AC QC, Governor of Victoria;
• 
  
• Mr Tony Weber, GM Innovation Analysis Branch, Innovation Division, Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government; and
• 
  
• Peter Beattie, Australian biotechnology advocate and former Premier of Queensland

Regarding the three remaining places to present, please contact AusBiotech’s Investment Program Manager, Hayley Laing or visit www.ausbiotech.org/investment.

Investors wishing to attend can register online – click here by Friday 7 June 2012.